<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">cardiovascular</journal-id><journal-title-group><journal-title xml:lang="ru">Кардиоваскулярная терапия и профилактика</journal-title><trans-title-group xml:lang="en"><trans-title>Cardiovascular Therapy and Prevention</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1728-8800</issn><issn pub-type="epub">2619-0125</issn><publisher><publisher-name>«SILICEA-POLIGRAF» LLC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.15829/1728-8800-2022-3314</article-id><article-id custom-type="elpub" pub-id-type="custom">cardiovascular-3314</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ХРОНИЧЕСКАЯ СЕРДЕЧНАЯ НЕДОСТАТОЧНОСТЬ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>CHRONIC HEART FAILURE</subject></subj-group></article-categories><title-group><article-title>Эхокардиографические характеристики больных хронической сердечной недостаточностью со сниженной фракцией выброса разного происхождения</article-title><trans-title-group xml:lang="en"><trans-title>Echocardiographic characteristics of patients with ischemic and non-ischemic chronic heart failure with reduced ejection fraction</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-1294-9646</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Илов</surname><given-names>Н. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Ilov</surname><given-names>N. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Николай Николаевич Илов — кандидат медицинских наук, доцент кафедры сердечно-сосудистой хирургии; врач-сердечно-сосудистый хирург отделения хирургического лечения сложных нарушений ритма сердца и электрокардиостимуляции</p><p>Астрахань</p></bio><bio xml:lang="en"><p>Nikolay Nikolaevich Ilov, Associate Professor of the department of cardiovascular surgery, Cardiovascular surgeon, M.D.</p><p>Astrakhan;</p></bio><email xlink:type="simple">nikolay.ilov@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-2400-8045</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Стомпель</surname><given-names>Д. Р.</given-names></name><name name-style="western" xml:lang="en"><surname>Stompel</surname><given-names>D. R.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Динара Рафаиловна Стомпель — ассистент кафедры сердечно-сосудистой хирургии; зав. отделением функциональной диагностики</p><p>Астрахань</p></bio><bio xml:lang="en"><p>Dinara Rafailovna Stompel, head of the department of functional diagnostics</p><p>Astrakhan;</p></bio><email xlink:type="simple">dinasto71@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-6998-8406</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Бойцов</surname><given-names>С. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Boytsov</surname><given-names>S. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Сергей Анатольевич Бойцов — доктор медицинских наук, профессор, академик РАН, генеральный директор</p><p>Москва</p></bio><bio xml:lang="en"><p>Sergey Anatolievich Boytsov, Director of the  National Medical Research Center of Cardiology of the Russian Ministry of Healthcare, Moscow, MD, PhD, Professor, Academician of the Russian Academy of Sciences</p><p>. Moscow</p><p> </p></bio><email xlink:type="simple">prof.boytsov@gmail.com</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-8153-6637</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Романцов</surname><given-names>Е. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Romantsov</surname><given-names>E. I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Евгений Игоревич Романцов — врач-кардиолог отделения хирургического лечения сложных нарушений ритма сердца и электрокардиостимуляции</p><p>Астрахань</p></bio><bio xml:lang="en"><p>Eugeny Igorevich Romantsov, cardiologist of the department of surgical treatment of complex arrhythmias and pacemaker implantations</p></bio><email xlink:type="simple">romantsov88@yandex.ru</email><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-5722-9883</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Нечепуренко</surname><given-names>А. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Nechepurenko</surname><given-names>A. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Анатолий Анатольевич Нечепуренко — кандидат медицинских наук, зав. отделением хирургического лечения сложных нарушений ритма сердца и электрокардиостимуляции</p><p>Астрахань</p></bio><bio xml:lang="en"><p>Anatoly Anatolievich Nechepurenko, head of the department of surgical treatment of complex arrhythmias and pacemaker implantations, M.D.</p><p>Astrakhan;</p></bio><email xlink:type="simple">vestik@mail.ru</email><xref ref-type="aff" rid="aff-3"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБОУ ВО "Астраханский государственный медицинский университет" Минздрава России;&#13;
ФГБУ "Федеральный центр сердечно-сосудистой хирургии" Минздрава России</institution></aff><aff xml:lang="en"><institution>Astrakhan State Medical University; &#13;
Federal Center for Cardiovascular Surgery</institution></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>ФГБУ "Национальный медицинский исследовательский центр кардиологии им. акад. Е. И. Чазова" Минздрава России</institution></aff><aff xml:lang="en"><institution>E. I. Chazov National Medical Research Center of Cardiology</institution></aff></aff-alternatives><aff-alternatives id="aff-3"><aff xml:lang="ru"><institution>ФГБУ "Федеральный центр сердечно-сосудистой хирургии" Минздрава России</institution></aff><aff xml:lang="en"><institution>Federal Center for Cardiovascular Surgery</institution></aff></aff-alternatives><pub-date pub-type="collection"><year>2022</year></pub-date><pub-date pub-type="epub"><day>12</day><month>09</month><year>2022</year></pub-date><volume>21</volume><issue>9</issue><fpage>3314</fpage><lpage>3314</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Илов Н.Н., Стомпель Д.Р., Бойцов С.А., Романцов Е.И., Нечепуренко А.А., 2022</copyright-statement><copyright-year>2022</copyright-year><copyright-holder xml:lang="ru">Илов Н.Н., Стомпель Д.Р., Бойцов С.А., Романцов Е.И., Нечепуренко А.А.</copyright-holder><copyright-holder xml:lang="en">Ilov N.N., Stompel D.R., Boytsov S.A., Romantsov E.I., Nechepurenko A.A.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://cardiovascular.elpub.ru/jour/article/view/3314">https://cardiovascular.elpub.ru/jour/article/view/3314</self-uri><abstract><p>Имеющиеся в литературе данные указывают на наличие различий в неблагоприятных исходах больных с хронической сердечной недостаточностью (ХСН) ишемического и неишемического генеза. Знания о структурно-функциональном состоянии миокарда, особенно левого желудочка (ЛЖ), при разных этиопатогенетических формах ХСН не являются достаточными для проведения точной стратификации риска нежелательных событий.</p><sec><title>Цель</title><p>Цель. Проведение сравнительного анализа эхокардиографических характеристик больных с ХСН и фракцией выброса (ФВ) ЛЖ ≤35% в зависимости от происхождения ХСН.</p></sec><sec><title>Материал и методы</title><p>Материал и методы. В исследование были включены 498 больных с ХСН III-IV функционального класса по классификации НьюЙоркской ассоциации сердца (New-York Heart Association) с ФВ ЛЖ ≤35%, принимающих оптимальную медикаментозную терапию. Были сформированы 2 группы больных с ХСН ишемического происхождения (n=254) и дилатационной кардиомиопатией (ДКМП) (n=244). Проводились двухмерная эхокардиография в Ви M-режиме, допплеровская эхокардиография с цветным допплеровским картированием кровотока, тканевая допплерография.</p></sec><sec><title>Результаты</title><p>Результаты. Исследованные больные с ХСН ишемического происхождения и ДКМП имели одинаковый паттерн ремоделирования ЛЖ (преимущественно по типу эксцентрической гипертрофии), но достоверно отличались по основным параметрам архитектоники ЛЖ: конечному систолическому и диастолическому размерам, объемам ЛЖ, массе миокарда ЛЖ и значениям этих показателей, индексированных по площади поверхности тела. Больные ДКМП имели бóльшую величину медиально-латерального размера и объема левого предсердия, у них чаще регистрировалась патологическая митральная и трикуспидальная регургитация.</p></sec><sec><title>Заключение</title><p>Заключение. Обнаружено, что размеры и объемы левых отделов сердца больных ДКМП превышают аналогичные параметры у пациентов с ХСН ишемического генеза. Возможная связь полученных результатов с будущими неблагоприятными исходами ХСН требует продолжения исследования.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>T</title><p>T</p><p>The data indicate differences in the adverse outcomes of chronic heart failure (CHF) in both ischemic (ICMP) and non-ischemic origins. The knowledge of the structural and functional myocardial state, especially of the left ventricle (LV), is insufficient for accurate risk stratification of unfavorable events in different etiopathogenetic forms of CHF.</p></sec><sec><title>Aim</title><p>Aim. To make a comparative analysis of echocardiographic characteristics of CHF patients with reduced LV ejection fraction (EF) ≤35% depending on the origin of CHF.</p></sec><sec><title>Material and methods</title><p>Material and methods. 498 patients of CHF 3-4 functional class of NYHA (New-York Heart Association) with EF ≤35% taking optimal drug </p><p>therapy were included in the study. Based on the etiology of CHF, two groups of patients with CHF of ischemic genesis (n=254) and dilated cardiomyopathy (DCMP, n=244) were formed. Two-dimensional echocardiography techniques in Band M-mode, color Doppler, and tissue Doppler imaging were carried out.</p></sec><sec><title>Results</title><p>Results. Patients with ICMP and DCMP had the same pattern of LV remodeling (mainly on the type of eccentric hypertrophy), but they reliably differed in the basic parameters of LV architectonics: endsystolic and end-diastolic dimensions, LV volume, LV myocardial mass and values of these indicators, indexed by body surface area. DCMP patients had a higher value of medial-lateral dimension and volume of left atrial, pathological mitral and tricuspid regurgitation was registered more often.</p></sec><sec><title>Conclusion</title><p>Conclusion. It was found that left heart dimensions and volumes of DCMP patients exceed similar parameters in patients with ICMP. The possible association of the results with future adverse outcomes of CHF demands further research.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>хроническая сердечная недостаточность</kwd><kwd>эхокардиография</kwd><kwd>левый желудочек</kwd><kwd>хроническая сердечная недостаточность ишемического происхождения</kwd><kwd>дилатационная кардиомиопатия</kwd></kwd-group><kwd-group xml:lang="en"><kwd>chronic heart failure</kwd><kwd>echocardiography</kwd><kwd>left ventricle.</kwd></kwd-group><funding-group><funding-statement xml:lang="ru">Конфликт интересов не заявляется.</funding-statement><funding-statement xml:lang="en">No conflict of interest is declared.</funding-statement></funding-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Виноградова Н.Г., Поляков Д.С., Фомин И.В. Анализ смертности у пациентов с ХСН после декомпенсации при длительном наблюдении в условиях специализированной медицинской помощи и в реальной клинической практике. Кардиология. 2020;60(4):91-100.https://doi.org/10.18087/cardio.2020.4.n1014.</mixed-citation><mixed-citation xml:lang="en">Vinogradova NG, Polyakov DS, Fomin IV. Analysis of mortality in patients with heart failure after de­compen­sation during long-term follow-up in specialized medical care and in real clinical practice. Kardiologiia 2020;60:91–100. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Поляков Д.С., Фомин И.В., Беленков Ю.Н., и др. Хроническая сердечная недостаточность в Российской Федерации: что изменилось за 20 лет наблюдения? Результаты исследования ЭПОХА -ХСН. Кардиология. 2021;61(4):4-14. https://doi.org/10.18087/cardio.2021.4.n1628.</mixed-citation><mixed-citation xml:lang="en">Polyakov DS, Fomin IV., Belenkov YN, et al. Chronic heart failure in the Russian Federation: what has changed over 20 years of follow-up? Results of the EPOCH-CHF study. Kardiologiia 2021;61:4–14. (In Russ.) https://doi.org/10.18087/cardio.2021.4.n1628.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">McDonagh TA, Metra M, Adamo M, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J 2021;42:3599–726. https://doi.org/10.1093/eurheartj/ehab368.</mixed-citation><mixed-citation xml:lang="en">McDonagh TA, Metra M, Adamo M, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J 2021;42:3599–726. https://doi.org/10.1093/eurheartj/ehab368.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Silverdal J, Sjöland H, Bollano E, et al. Prognostic impact over time of ischaemic heart disease vs. non‐ischaemic heart disease in heart failure. ESC Hear Fail. 2020;7:265–74. https://doi.org/10.1002/ehf2.12568.</mixed-citation><mixed-citation xml:lang="en">Silverdal J, Sjöland H, Bollano E, et al. Prognostic impact over time of ischaemic heart disease vs. non‐ischaemic heart disease in heart failure. ESC Hear Fail. 2020;7:265–74. https://doi.org/10.1002/ehf2.12568.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Beiert T, Straesser S, Malotki R, et al.. Increased mortality and ICD therapies in ischemic versus non-ischemic dilated cardiomyopathy patients with cardiac resynchronization having survived until first device replacement. Arch Med Sci AMS 2019;15:845. doi: 10.5114/aoms.2018.75139.</mixed-citation><mixed-citation xml:lang="en">Beiert T, Straesser S, Malotki R, et al.. Increased mortality and ICD therapies in ischemic versus non-ischemic dilated cardiomyopathy patients with cardiac resynchronization having survived until first device replacement. Arch Med Sci AMS 2019;15:845. doi: 10.5114/aoms.2018.75139.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Колоцей ЛВ, Снежицкий ВА. Электрокардиографические и визуализирующие методы исследования в стратификации риска внезапной сердечной смерти у пациентов с хронической сердечной недостаточностью. Вестник аритмологии. 2021;28(2): 28-36. https://doi.org/10.35336/VA-2021-2-28-36.</mixed-citation><mixed-citation xml:lang="en">Kalatsei LV, Snezhitskiy VA. Electrocardiographic and imaging methods in risk stratification of sudden cardiac death in patients with chronic heart failure. Journal of Arrhythmology. 2021;28(2): 28-36. (In Russ.) https://doi.org/10.35336/VA-2021-2-28-36.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Илов Н.Н., Пальникова О.В., Стомпель Д.Р., и др. Стратификация риска внезапной сердечной смерти у пациентов с сердечной недостаточностью: достаточно ли одной фракции выброса левого желудочка? Российский кардиологический журнал. 2021;26(1):3959. https://doi.org/10.15829/1560-4071-2021-3959.</mixed-citation><mixed-citation xml:lang="en">Ilov NN, Palnikova OV, Stompel DR, et al. Risk stratification of sudden cardiac death in heart failure patients: is left ventricular ejection fraction alone sufficient? Russian Journal of Cardiology. 2021;26(1):3959. (In Russ.) https://doi.org/10.15829/1560-4071-2021-3959.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Lang RM, Badano LP, Mor-Avi V, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: An update from the American society of echocardiography and the European association of cardiovascular imaging. Eur Heart J Cardiovasc Imaging 2015;16:233–71. https://doi.org/10.1093/ehjci/jev014.</mixed-citation><mixed-citation xml:lang="en">Lang RM, Badano LP, Mor-Avi V, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: An update from the American society of echocardiography and the European association of cardiovascular imaging. Eur Heart J Cardiovasc Imaging 2015;16:233–71. https://doi.org/10.1093/ehjci/jev014.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Seko Y, Kato T, Haruna T, et al. Association between atrial fibrillation, atrial enlargement, and left ventricular geometric remodeling. Sci Rep. 2018;8:6366. https://doi.org/10.1038/s41598-018-24875-1.</mixed-citation><mixed-citation xml:lang="en">Seko Y, Kato T, Haruna T, et al. Association between atrial fibrillation, atrial enlargement, and left ventricular geometric remodeling. Sci Rep. 2018;8:6366. https://doi.org/10.1038/s41598-018-24875-1.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Lee Y-H, Chiou W-R, Hsu C-Y, et al. Different left ventricular remodelling patterns and clinical outcomes between non-ischaemic and ischaemic aetiologies in heart failure patients receiving sacubitril/valsartan treatment. Eur Hear J - Cardiovasc Pharmacother. 2022;8:118–29. https://doi.org/10.1093/ehjcvp/pvaa125.</mixed-citation><mixed-citation xml:lang="en">Lee Y-H, Chiou W-R, Hsu C-Y, et al. Different left ventricular remodelling patterns and clinical outcomes between non-ischaemic and ischaemic aetiologies in heart failure patients receiving sacubitril/valsartan treatment. Eur Hear J - Cardiovasc Pharmacother. 2022;8:118–29. https://doi.org/10.1093/ehjcvp/pvaa125.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Frangogiannis NG. The extracellular matrix in ischemic and nonischemic heart failure. Heart Failure. 2019:117–46. https://doi.org/10.1161/CIRCRESAHA.119.311148.</mixed-citation><mixed-citation xml:lang="en">Frangogiannis NG. The extracellular matrix in ischemic and nonischemic heart failure. Heart Failure. 2019:117–46. https://doi.org/10.1161/CIRCRESAHA.119.311148.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Zhao Y, Godier-Furnemont A, Bax NAM, et al. Changes in extracellular matrix in failing human non-ischemic and ischemic hearts with mechanical unloading. J Mol Cell Cardiol. 2022;166:137–51. https://doi.org/10.1016/j.yjmcc.2022.02.003.</mixed-citation><mixed-citation xml:lang="en">Zhao Y, Godier-Furnemont A, Bax NAM, et al. Changes in extracellular matrix in failing human non-ischemic and ischemic hearts with mechanical unloading. J Mol Cell Cardiol. 2022;166:137–51. https://doi.org/10.1016/j.yjmcc.2022.02.003.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Romuk E, Wojciechowska C, Jacheć W, et al. Comparison of Oxidative Stress Parameters in Heart Failure Patients Depending on Ischaemic or Nonischaemic Aetiology. Oxid Med Cell Longev. 2019;2019:1–13. https://doi.org/10.1155/2019/7156038.</mixed-citation><mixed-citation xml:lang="en">Romuk E, Wojciechowska C, Jacheć W, et al. Comparison of Oxidative Stress Parameters in Heart Failure Patients Depending on Ischaemic or Nonischaemic Aetiology. Oxid Med Cell Longev. 2019;2019:1–13. https://doi.org/10.1155/2019/7156038.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Павлюкова Е.Н., Кужель Д.А., Матюшин Г.В. Функция левого предсердия: современные методы оценки и клиническое значение. Рациональная Фармакотерапия в Кардиологии. 2017;13(5):675-683. https://doi.org/10.20996/1819-6446-2017-13-5-675-683.</mixed-citation><mixed-citation xml:lang="en">Pavlyukova EN, Kuzhel DA, Matyushin GV. Left atrial function: modern assessment methods and clinical significance. Rational Pharmacotherapy in Cardiology. 2017;13(5):675-683. (In Russ.) https://doi.org/10.20996/1819-6446-2017-13-5-675-683.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Ogawa S, Nagatomo Y, Takei M, et al. Impact of Left Ventricular Chamber Size on Outcome in Heart Failure with Preserved Ejection Fraction. 2021:62–72. https://doi.org/10.1536/ihj.21-486.</mixed-citation><mixed-citation xml:lang="en">Ogawa S, Nagatomo Y, Takei M, et al. Impact of Left Ventricular Chamber Size on Outcome in Heart Failure with Preserved Ejection Fraction. 2021:62–72. https://doi.org/10.1536/ihj.21-486.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Shah MA, Soofi MA, Jafary Z, et al. Echocardiographic parameters associated with recovery in heart failure with reduced ejection fraction. Echocardiography. 2020;37:1574–82. https://doi.org/10.1111/echo.14859.</mixed-citation><mixed-citation xml:lang="en">Shah MA, Soofi MA, Jafary Z, et al. Echocardiographic parameters associated with recovery in heart failure with reduced ejection fraction. Echocardiography. 2020;37:1574–82. https://doi.org/10.1111/echo.14859.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Froehlich L, Meyre P, Aeschbacher S, et al. Left atrial dimension and cardiovascular outcomes in patients with and without atrial fibrillation: a systematic review and meta-analysis. Heart. 2019;105:1884–91. https://doi.org/10.1136/heartjnl-2019-315174.</mixed-citation><mixed-citation xml:lang="en">Froehlich L, Meyre P, Aeschbacher S, et al. Left atrial dimension and cardiovascular outcomes in patients with and without atrial fibrillation: a systematic review and meta-analysis. Heart. 2019;105:1884–91. https://doi.org/10.1136/heartjnl-2019-315174.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
